Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells

Table 6 Frequency of use of iMSC surface markers

Positive CSM	%	Negative CSM	%
CD73	18.1	CD45	24.5
CD105	17.1	CD34	23.0
CD90	15.7	CD14	8.6
CD44	12.5	CD31	7.2
CD29	9.3	HLA-DR	5.8
CD166	6.9	CD11b	5.0
CD146	3.7	CD133	2.9
CD49(a)	2.8	TRA181	2.9
HLA-ABC	2.3	CD19	2.2
CD49(e)	1.9	CD24	2.2
CD106	1.4	CD3	1.4
CD271	1.4	CD40	1.4
CD49(d)	0.9	CD56	1.4
CD140alpha	0.9	CD80	1.4
Sca1	0.9	CD86	1.4
CD33	0.5	Oct3/4	1.4
CD49(f)	0.5	CD4	0.7
CD54	0.5	CD20	0.7
CD71	0.5	CD79a	0.7
CD140(b)	0.5	CD117	0.7
CD144	0.5	CD309	0.7
CD172alpha	0.5	Sox2	0.7
αSMA+	0.5	TRA-160	0.7
Stro1	0.5	TRA-161	0.7
		TRA180	0.7
		SSEA-4	0.7

Positive and negative surface expression markers found in mesenchymal stem cells are listed together with the frequency of findings (%) in the reviewed studies (n = 44). CD: Cluster of differentiation; CSM: Cell surface marker; HLA: Human leukocyte antigen; SSEA: Stage specific embryonic antigen; TRA: Teratocarcinoma surface antigen.